Electric Literature of 253-52-1, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 253-52-1, Name is Phthalazine, molecular formula is C8H6N2. In a Patent£¬once mentioned of 253-52-1
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR AND OTHER ASSOCIATED DISORDERS
Pharmaceutical compositions comprising at least one endothelin conversion enzyme (ECE) inhibitor and/or neutral endopeptidase (NEP) inhibitor in combination with at least one another active agent optionally with other pharmaceutically acceptable excipients useful in the prophylaxis, treatment and/or amelioration of cardiovascular and other associated disorders such as one or more of coronary artery disease, congestive heart failure, angina, atherosclerosis, hyperlipidemia, diabetes, neurodegenerative disorders or the like are provided. Also described are process for preparation of such compositions and method of using such compositions.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Electric Literature of 253-52-1. In my other articles, you can also check out more blogs about 253-52-1
Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N9 – PubChem